Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Growth Paris  >  Theranexus    ALTHX   FR0013286259

THERANEXUS

(ALTHX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news
Most relevant news about THERANEXUS
11/20THERANEXUS : - The Food And Drug Administration issues a favorable opinion on th..
AQ
11/20THERANEXUS : The Food And Drug Administration (FDA) issues a favorable opinion o..
PU
11/19THERANEXUS : The food and drug administration (fda) issues a favorable opinion o..
AN
11/05THERANEXUS : - Presentation of the results of the phase 1b clinical study with T..
AQ
11/04THERANEXUS : Presentation of the results of the phase 1b clinical study of THN20..
PU
11/04THERANEXUS : Presentation of the results of the phase ib clinical study of thn20..
AN
10/22THERANEXUS : TTHERANEXUS and the BBDF Foundation Obtain Orphan Drug Status in Eu..
AQ
10/21THERANEXUS : and BBDF obtain European "orphan medicinal product" designation for..
PU
10/16THERANEXUS : publishes its cash position as of September 30, 2020
AQ
10/15THERANEXUS : 3rd quarter earnings
CO
09/30THERANEXUS : announces its first half results
AQ
09/29THERANEXUS : Half-year results
CO
09/10THERANEXUS : takes stock of its scientific news
AQ
09/09THERANEXUS : Theranexus presents its latest scientific news
AN
08/31THERANEXUS : Monthly statement on outstanding equity shares and voting rights
CO
More most relevant news
All news about THERANEXUS
11/20THERANEXUS : - The Food And Drug Administration issues a favorable opinion on th..
AQ
11/20THERANEXUS : The Food And Drug Administration (FDA) issues a favorable opinion o..
PU
11/19THERANEXUS : The food and drug administration (fda) issues a favorable opinion o..
AN
11/05THERANEXUS : - Presentation of the results of the phase 1b clinical study with T..
AQ
11/04THERANEXUS : Presentation of the results of the phase 1b clinical study of THN20..
PU
11/04THERANEXUS : Presentation of the results of the phase ib clinical study of thn20..
AN
10/22THERANEXUS : TTHERANEXUS and the BBDF Foundation Obtain Orphan Drug Status in Eu..
AQ
10/21THERANEXUS : and BBDF obtain European "orphan medicinal product" designation for..
PU
10/16THERANEXUS : publishes its cash position as of September 30, 2020
AQ
10/15THERANEXUS : 3rd quarter earnings
CO
More news
News in other languages on THERANEXUS
11/20THERANEXUS : La Food And Drug Administration (FDA) rend un avis favorable au pla..
11/19THERANEXUS : recherché grâce à la FDA
11/19La 2e vague fond sur les Etats-Unis
11/19STOCK MARKET PARIS : Les valeurs à suivre à Paris et en Europe
11/19EN DIRECT DES MARCHES : Bouygues, Unibail, Vallourec, Soitec, Starbucks, Apple, ..
11/19THERANEXUS : La food and drug administration (fda) rend un avis favorable au pla..
11/05EN DIRECT DES MARCHES : ArcelorMittal, Société Générale, Veolia, CGG, Lufthansa,..
11/05Insoutenable
11/04THERANEXUS : Présentation des résultats de l'étude clinique de phase 1b avec THN..
11/04THERANEXUS : PRÉSENTATION DES RÉSULTATS DE L’ÉTUDE CLINIQUE DE PHASE 1b AVEC THN..
Press releases
11/20THERANEXUS : - The Food And Drug Administration issues a favorable opinion on th..
AQ
11/20THERANEXUS : The Food And Drug Administration (FDA) issues a favorable opinion o..
PU
11/19THERANEXUS : The food and drug administration (fda) issues a favorable opinion o..
AN
11/05THERANEXUS : - Presentation of the results of the phase 1b clinical study with T..
AQ
11/04THERANEXUS : Presentation of the results of the phase 1b clinical study of THN20..
PU
More press releases